secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zymeworks Inc. (ZYME)
CIK:        0001937653
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0001193125-22-281294
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zymeworks enters into ATM equity offering agreement with Cantor Fitzgerald
--------------------------------------------------------------------------

- Sales Agreement allows at-the-market sales of common stock through Cantor as agent.
- Commission of up to 3.0% of gross proceeds; company not obligated to sell shares.
- Offering under existing S-3ASR; prospectus supplement filed November 9, 2022.
- Provides flexible capital raising subject to market conditions and company instructions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937653/000119312522281294/0001193125-22-281294-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937653/000119312522281294/d407989d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-281294

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer